New hope for tough brain cancer: trial tests powerful Immune-Boosting combo

NCT ID NCT06931652

Summary

This study is testing a new three-drug combination for people with an aggressive type of brain lymphoma that has come back or stopped responding to prior treatment. The goal is to see if adding a new immune-boosting drug called epcoritamab to two existing drugs can better control the cancer and improve survival. The trial will enroll about 60 adults to measure how well the tumors shrink and monitor side effects.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRIMARY CNS LYMPHOMA (PCNSL) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CHR DE MARSEILLE - CHU TIMONE - Service de Neuro-Oncologie

    ACTIVE_NOT_RECRUITING

    Marseille, France

  • CHRU DE NANCY - HOPITAL CENTRAL - Service de Neurologie

    ACTIVE_NOT_RECRUITING

    Nancy, France

  • CHU BRETONNEAU - Service Cancérologie - Hématologie et Thérapie Cellulaire

    ACTIVE_NOT_RECRUITING

    Tours, France

  • CHU DE LILLE - HOPITAL CLAUDE HURIEZ - Service des Maladies du Sang

    RECRUITING

    Lille, France

    Contact

  • CHU ESTAING - Service Thérapie Cellulaire et Hématologie Clinique

    RECRUITING

    Clermont-Ferrand, France

    Contact

  • CHU LYON-SUD - Hématologie Clinique

    RECRUITING

    Pierre-Bénite, France

    Contact

  • CHU PONTCHAILLOU - Hématologie Clinique

    NOT_YET_RECRUITING

    Rennes, France

    Contact

  • GHU PITIE-SALPETRIERE - CHARLES FOIX - Service Neurologie

    ACTIVE_NOT_RECRUITING

    Paris, France

  • HOPITAL DE LA PITIE SALPETRIERE - Service Hématologie Clinique

    ACTIVE_NOT_RECRUITING

    Paris, France

  • INSTITUT BERGONIE - Service d'Oncologie Médicale

    ACTIVE_NOT_RECRUITING

    Bordeaux, France

  • INSTITUT CURIE - SITE SAINT-CLOUD - Service Hématologie

    ACTIVE_NOT_RECRUITING

    Saint-Cloud, France

  • INSTITUT D'HEMATOLOGIE DE BASSE NORMANDIE - Service Hématologie

    RECRUITING

    Caen, France

    Contact

  • IUCT ONCOPOLE - Service Hématologie

    RECRUITING

    Toulouse, France

    Contact

Conditions

Explore the condition pages connected to this study.